Literature DB >> 1575981

A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test.

B Bosman1, T Matthiesen, V Hess, E Friderichs.   

Abstract

Topical treatment of the mouse tail with antipsoriatic drugs enhances orthokeratotic cell differentiation in the epidermal scales. We developed a new evaluation system for this test which allows quantification of drug efficacy. Drugs were applied topically, once daily, 5 times a week, for 2 weeks. Two hours after the last treatment the animals were sacrificed, longitudinal sections of the tail skin were made and prepared for histological examination (hematoxylin-eosin staining). As indicator of orthokeratosis (OK), the length of the granular layer per scale was measured microscopically with a semiautomatic image evaluation unit and related to the total scale length (= % OK per scale). Drug activity was defined by the increase in the total length of orthokeratotic regions, 100% activity corresponds to a granular layer extending over the whole scale length. In this model dithranol and retinoic acid dose-dependently increased orthokeratosis up to 75 and 79%, respectively. Beech tar, in a concentration of 5% induced a 19% increase in orthokeratosis. Morphometric quantification by image analysis of the conversion of parakeratotic into orthokeratotic regions in mouse tail scales induced by topical drug treatment seems to be a suitable and reliable procedure to investigate new drugs from which antipsoriatic activity may be expected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575981     DOI: 10.1159/000211016

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  5 in total

1.  Effects of baicalin cream in two mouse models: 2,4-dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis.

Authors:  Jie Wu; Hong Li; Ming Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis.

Authors:  Diana Ana-Maria Nițescu; Horia Păunescu; Alina Elena Ștefan; Laurențiu Coman; Corneliu Cristian Georgescu; Andrei Constantin Stoian; Daniela Gologan; Ion Fulga; Oana Andreia Coman
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

3.  Effects of artemether on the proliferation, apoptosis, and differentiation of keratinocytes: potential application for psoriasis treatment.

Authors:  Jie Wu; Hong Li; Ming Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Screening of flavonoid "quercetin" from the rhizome of Smilax china Linn. for anti-psoriatic activity.

Authors:  A Vijayalakshmi; V Ravichandiran; Velraj Malarkodi; S Nirmala; S Jayakumari
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

5.  Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.

Authors:  Theresa Benezeder; Clemens Painsi; VijayKumar Patra; Saptaswa Dey; Martin Holcmann; Bernhard Lange-Asschenfeldt; Maria Sibilia; Peter Wolf
Journal:  Elife       Date:  2020-06-02       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.